Cargando…
Inhaled sGC Modulator Can Lower PH in Patients With COPD Without Deteriorating Oxygenation
This study uses a highly fidelity computational simulator of pulmonary physiology to evaluate the impact of a soluble guanylate cyclase (sGC) modulator on gas exchange in patients with chronic obstructive pulmonary disease (COPD) and pulmonary hypertension (PH) as a complication. Three virtual patie...
Autores principales: | Saffaran, Sina, Wang, Wenfei, Das, Anup, Schmitt, Walter, Becker‐Pelster, Eva‐Maria, Hardman, Jonathan G., Weimann, Gerrit, Bates, Declan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118299/ https://www.ncbi.nlm.nih.gov/pubmed/29962065 http://dx.doi.org/10.1002/psp4.12308 |
Ejemplares similares
-
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC
por: Becker-Pelster, Eva M., et al.
Publicado: (2022) -
Inhaled nitric oxide: an sGC-dependent IOP lowering agent
por: Lieb, Wolfgang S, et al.
Publicado: (2015) -
Structural insights into sGC
por: Akker, Focco van den, et al.
Publicado: (2009) -
Can computer simulators accurately represent the pathophysiology of individual COPD patients?
por: Wang, Wenfei, et al.
Publicado: (2014) -
Conformational changes involved in sGC activation
por: Marletta, Michael A, et al.
Publicado: (2013)